Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Emerald Health Pharmaceuticals Initiates Phase I Clinical Study on its Oral Drug Candidate Derived from Cannabidiol

pharmafocusasiaSeptember 29, 2018

Tag: Emerald Health , Oral Drug Candidate Derived , Cannabidiol

PharmaSources Customer Service